Published by Iain Gilbert on 29th April 2026
(Sharecast News) - Drugmaker AstraZeneca said on Wednesday that it had delivered solid revenue growth and a series of positive late‑stage trial readouts in the first quarter, reinforcing confidence in its 2030 ambitions.
URL: http://www.digitallook.com/dl/news/story/35896896/...